Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company. The press release was errantly issued by the newswire services under the Company’s name. The Company has not scheduled any earnings calls. The Company is investigating how this error occurred and reserves all rights to pursue all appropriate remedies upon learning more about the cause of this error.

Investor Relations: Hayden IR Brett Mass, Managing Partner Phone: (646) 536-7331 Email: brett@haydenir.com www.haydenir.com

Akers Biosciences (NASDAQ:AKER)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Akers Biosciences 차트를 더 보려면 여기를 클릭.
Akers Biosciences (NASDAQ:AKER)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Akers Biosciences 차트를 더 보려면 여기를 클릭.